255 related articles for article (PubMed ID: 3206109)
1. Pancreatic oncofetal antigen and carcinoembryonic antigen in breast and colon carcinoma.
Kithier K; Samal B; Cejka J; Whitcomb MP; Mood DW
Tumour Biol; 1988; 9(6):307-14. PubMed ID: 3206109
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of pancreatic oncofetal antigen (POA) in the diagnosis of pancreatic cancer].
Nishida K
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):601-8. PubMed ID: 6349542
[TBL] [Abstract][Full Text] [Related]
3. The production of carcinoembryonic antigen (CEA) by human colonic carcinomas and normal colonic mucosa in monolayer and organ culture.
Breborowicz J; Easty GC; Neville AM
Ann Immunol (Paris); 1973 Nov; 124(4):613-4. PubMed ID: 4792499
[No Abstract] [Full Text] [Related]
4. [Sensitivity and specificity of CEA, Ca 15-3 and MCA levels in visceral breast carcinoma metastasis].
Delbrück H; Hagen-Aukamp C; Braun G
Strahlenther Onkol; 1990 Jul; 166(7):457-9. PubMed ID: 2200152
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic significance of cancer antigen 125, pancreatic oncofetal antigen, and carcinoembryonic antigen in malignant and tuberculous pleural effusions.
Niwa Y; Shimokata K
Jpn J Clin Oncol; 1986 Mar; 16(1):3-8. PubMed ID: 3009919
[TBL] [Abstract][Full Text] [Related]
6. Production of monoclonal antibodies to serum antigens in colorectal carcinoma.
Teh JG; Thompson CH; McKenzie IF
J Immunol Methods; 1988 May; 110(1):101-9. PubMed ID: 3286775
[TBL] [Abstract][Full Text] [Related]
7. Tissue concentrations of CEA and CA 19-9 in the carcinogenesis of colorectal carcinoma exemplified by the adenoma-carcinoma sequence.
Fischbach W; Mössner J
Res Exp Med (Berl); 1988; 188(2):101-14. PubMed ID: 3163815
[TBL] [Abstract][Full Text] [Related]
8. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A
Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091
[TBL] [Abstract][Full Text] [Related]
9. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD
Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729
[TBL] [Abstract][Full Text] [Related]
10. The value of CA 19-9 in gastric and colorectal carcinoma.
Safi F; Bittner R; Roscher R; Kübel R; Beger HG
Cancer Invest; 1987; 5(5):401-7. PubMed ID: 3480768
[TBL] [Abstract][Full Text] [Related]
11. [Pancreatic oncofetal antigen (POA) and carcinoma of the pancreas].
Homma T; Oguchi H; Kawa S; Nagata A; Furuta S
Gan No Rinsho; 1984 May; 30(6 Suppl):558-62. PubMed ID: 6205174
[TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen, CA 19-9, and CA 125 in normal and carcinomatous human colorectal tissue.
Quentmeier A; Möller P; Schwarz V; Abel U; Schlag P
Cancer; 1987 Nov; 60(9):2261-6. PubMed ID: 3481558
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma.
Gion M; Mione R; Dittadi R; Fasan S; Pallini A; Bruscagnin G
Cancer; 1986 Mar; 57(5):917-22. PubMed ID: 3943025
[TBL] [Abstract][Full Text] [Related]
14. Evidence for common and distinct determinants of colon carcinoembryonic antigen, colon carcinoma antigen-III, and molecules with carcinoembryonic antigen activity isolated from breast and ovarian cancer.
Chism SE; Warner NL; Wells JV; Crewther P; Hunt S; Marchalonis JJ; Fudenberg HH
Cancer Res; 1977 Sep; 37(9):3100-8. PubMed ID: 69490
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients.
Shively JE; Spayth V; Chang FF; Metter GE; Klein L; Presant CA; Todd CW
Cancer Res; 1982 Jun; 42(6):2506-13. PubMed ID: 7074626
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen in patients with breast or colon cancer.
Lee YN
West J Med; 1978 Nov; 129(5):374-80. PubMed ID: 364839
[TBL] [Abstract][Full Text] [Related]
17. TA90-IC, a new marker for advanced colon cancer.
Habal N; Gupta RK; Bilchik AJ; Johnson T; Morton DL
Ann Surg Oncol; 2000 Jun; 7(5):352-6. PubMed ID: 10864342
[TBL] [Abstract][Full Text] [Related]
18. Markers in breast cancer: does CEA add to the detection by CA 15.3?
Delarue JC; Mouriesse H; Dubois F; Friedman S; May-Levin F
Breast Cancer Res Treat; 1988 Jul; 11(3):273-6. PubMed ID: 3167234
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of MSA as a serum marker in breast cancer: a comparison with CEA.
Stacker SA; Sacks NP; Golder J; Tjandra JJ; Thompson CH; Smithyman A; McKenzie IF
Br J Cancer; 1988 Mar; 57(3):298-303. PubMed ID: 3355770
[TBL] [Abstract][Full Text] [Related]
20. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
Wu JT
Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
